Scientific,
Stem Cell Biology,
Molecular & Cellular Biology,
Technology
IMBA receives 1.1 Mio funding by the European Commission for COVID-19 research
IMBA is part of the MAD-CoV 2 project and is funded with 1.1 Million Euros by the European Commission for developing antivirals against SARS-CoV-2.